低剂量与高剂量LSD辅助治疗在重度抑郁症患者中的有效性和安全性:一项随机试验
Felix Müller1, Hannes Zaczek2, Anna M Becker3
1University of Basel, Department of Psychiatry (UPK), 4012 Basel, Switzerland; University Hospital Basel and University of Basel, Division of Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research, 4031 Basel, Switzerland.
Med (New York, N.Y.)
|June 7, 2025
概括
这项研究探讨了对严重抑郁症的lysergic acid diethylamide (LSD) 辅助疗法. 高剂量的LSD在减少抑郁症状方面显示出有希望的结果,这需要进一步调查.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 重度抑郁症 (MDD) 是一种普遍且令人衰弱的心理健康状况.
- 目前用于MDD的治疗方法对某些患者的疗效和耐受性有局限性.
- Lysergic acid diethylamide (LSD) 正在作为治疗精神疾病的潜在新型治疗剂进行研究.
研究的目的:
- 评估LSD辅助治疗在中度至重度MDD患者中的疗效和安全性.
- 为了比较两个不同的LSD剂量方案与心理治疗结合的效果.
- 用标准化评分表来评估抑郁症状严重程度的变化.
主要方法:
- 进行了一项随机,并行组,双盲,低剂量受控试验.
- 患者接受了高剂量 (100微克+200微克) 或低剂量 (25微克+25微克) 的支持性心理治疗.
- 主要结局是从基线到治疗后2周的抑郁症状评分库存的变化.
主要成果:
- 高剂量LSD组显示临床医生评估的抑郁症状有统计学显著的减少 (p = 0.023).
- 在高剂量组中,自我评估的抑郁症状也呈现出数值改善,尽管在统计学上并不显著 (p = 0.059).
- 这些改善持续了长达12周,两组之间出现了相似的不良事件.
结论:
- 使用LSD辅助疗法在治疗严重抑郁症方面显示出潜在的有效性.
- 这些发现支持进一步研究LSD辅助治疗抑郁症的研究.
- 建议进行更大规模的第三期试验,以证实这些探索性发现.
相关概念视频
01:30Electroconvulsive Therapy
927
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
927
01:23Antidepressant Drugs: MAOIs and Other Agents
831
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
831
01:28Drug Therapy
246
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
246